Page last updated: 2024-11-13

N-cyclopropyl-3-{4-[(cyclopropylmethyl)carbamoyl]phenyl}-4-methylbenzamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-cyclopropyl-3-{4-[(cyclopropylmethyl)carbamoyl]phenyl}-4-methylbenzamide : A dicarboxylic acid diamide obtained by condensation of the 3- and 4'-carboxy groups of 6-methyl[1,1'-biphenyl]-3,4'-dicarboxylic acid with cyclpropylamine and cyclpropylmethylamine respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID24856363
CHEMBL ID478649
CHEBI ID90527
SCHEMBL ID6744546

Synonyms (26)

Synonym
n~3~-cyclopropyl-n~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide
gk5 ,
DB07835
6-methyl-biphenyl-3,4''-dicarboxylic acid 3-cyclopropylamide 4''-cyclopropylmethyl-amide
n~3~-cyclopropyl-n~4~''-(cyclopropylmethyl)-6-methylbiphenyl-3,4''-dicarboxamide
bdbm50263093
n3-cyclopropyl-n4''-(cyclopropylmethyl)-6-methylbiphenyl-3,4''-dicarboxamide
CHEMBL478649 ,
chebi:90527 ,
n-cyclopropyl-3-[4-(cyclopropylmethylcarbamoyl)phenyl]-4-methylbenzamide
n3-cyclopropyl-n4'-cyclopropylmethyl-6-methyl-1,1'-biphenyl-3,4'-dicarboxamide
BOPSUAHGQHFKGG-UHFFFAOYSA-N
SCHEMBL6744546
n-cyclopropyl-3-{4-[(cyclopropylmethyl)carbamoyl]phenyl}-4-methylbenzamide
n(3)-cyclopropyl-n(4')-(cyclopropylmethyl)-6-methyl[1,1'-biphenyl]-3,4'-dicarboxamide
n3-cyclopropyl-n4'-(cyclopropylmethyl)-6-methyl-3,4'-biphenyldicarboxamide
[1,1'-biphenyl]-3,4'-dicarboxamide, n3-cyclopropyl-n4'-(cyclopropylmethyl)-6-methyl-
Q27097044
[1,1'-biphenyl]-3,4'-dicarboxamide,n3-cyclopropyl-n4'-(cyclopropylmethyl)-6-methyl-
515134-70-0
unii-ath2ghg7lr
ATH2GHG7LR ,
(1,1'-biphenyl)-3,4'-dicarboxamide, n3-cyclopropyl-n4'-(cyclopropylmethyl)-6-methyl-
n-cyclopropyl-3-(4-(cyclopropylmethylcarbamoyl)phenyl)-4-methyl-benzamide
PD004968
n3-cyclopropyl-n4'-(cyclopropylmethyl)-6-methyl-[1,1'-biphenyl]-3,4'-dicarboxamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitorAn EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of mitogen-activated protein kinase (EC 2.7.11.24).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
biphenylsBenzenoid aromatic compounds containing two phenyl or substituted-phenyl groups which are joined together by a single bond.
dicarboxylic acid diamide
benzamides
cyclopropanesCyclopropane and its derivatives formed by substitution.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (18)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Serine/threonine-protein kinase Sgk1Homo sapiens (human)IC50 (µMol)33.00000.00680.86653.5700AID349064
Epidermal growth factor receptorHomo sapiens (human)IC50 (µMol)25.00000.00000.536910.0000AID349059
Heat shock protein beta-1Homo sapiens (human)IC50 (µMol)0.05300.02500.09920.2000AID341051
Cytochrome P450 1A2Homo sapiens (human)IC50 (µMol)10.00000.00011.774010.0000AID342134
Tyrosine-protein kinase LckHomo sapiens (human)IC50 (µMol)16.00000.00021.317310.0000AID349062
Macrophage colony-stimulating factor 1 receptorHomo sapiens (human)IC50 (µMol)20.00000.00060.56765.5450AID349058
Cytochrome P450 3A4Homo sapiens (human)IC50 (µMol)10.00000.00011.753610.0000AID342137
Cytochrome P450 2D6Homo sapiens (human)IC50 (µMol)10.00000.00002.015110.0000AID342136
Cytochrome P450 2C9 Homo sapiens (human)IC50 (µMol)4.19050.00002.800510.0000AID342138; AID599584
Cyclin-dependent kinase 2Homo sapiens (human)IC50 (µMol)20.00000.00041.044410.0000AID349057
Cytochrome P450 2C19Homo sapiens (human)IC50 (µMol)10.00000.00002.398310.0000AID342135
Vascular endothelial growth factor receptor 2Homo sapiens (human)IC50 (µMol)20.00000.00000.48308.8000AID349065
Serine/threonine-protein kinase PLK1Homo sapiens (human)IC50 (µMol)25.00000.00010.77349.0000AID349063
Mitogen-activated protein kinase 10Homo sapiens (human)IC50 (µMol)16.00000.00201.703510.0000AID349061
Dual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)IC50 (µMol)50.00000.00020.68139.7000AID349056
Receptor tyrosine-protein kinase erbB-4Homo sapiens (human)IC50 (µMol)25.00000.00010.17362.5900AID349060
Mitogen-activated protein kinase 11Homo sapiens (human)IC50 (µMol)1.00000.00070.47546.3000AID341194
Mitogen-activated protein kinase 11Homo sapiens (human)Ki0.02400.00080.05580.2200AID342124
Mitogen-activated protein kinase 14Homo sapiens (human)IC50 (µMol)0.09190.00010.72667.8000AID1540358; AID341052; AID342123; AID599582
Mitogen-activated protein kinase 14Homo sapiens (human)Ki0.01150.00010.07490.3100AID1540358; AID341049; AID341050; AID342123; AID342149; AID599580
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (432)

Processvia Protein(s)Taxonomy
regulation of cell growthSerine/threonine-protein kinase Sgk1Homo sapiens (human)
protein phosphorylationSerine/threonine-protein kinase Sgk1Homo sapiens (human)
sodium ion transportSerine/threonine-protein kinase Sgk1Homo sapiens (human)
apoptotic processSerine/threonine-protein kinase Sgk1Homo sapiens (human)
DNA damage responseSerine/threonine-protein kinase Sgk1Homo sapiens (human)
long-term memorySerine/threonine-protein kinase Sgk1Homo sapiens (human)
regulation of blood pressureSerine/threonine-protein kinase Sgk1Homo sapiens (human)
regulation of cell migrationSerine/threonine-protein kinase Sgk1Homo sapiens (human)
positive regulation of transporter activitySerine/threonine-protein kinase Sgk1Homo sapiens (human)
regulation of cell population proliferationSerine/threonine-protein kinase Sgk1Homo sapiens (human)
regulation of apoptotic processSerine/threonine-protein kinase Sgk1Homo sapiens (human)
regulation of catalytic activitySerine/threonine-protein kinase Sgk1Homo sapiens (human)
regulation of DNA-binding transcription factor activitySerine/threonine-protein kinase Sgk1Homo sapiens (human)
regulation of gastric acid secretionSerine/threonine-protein kinase Sgk1Homo sapiens (human)
renal sodium ion absorptionSerine/threonine-protein kinase Sgk1Homo sapiens (human)
regulation of signal transduction by p53 class mediatorSerine/threonine-protein kinase Sgk1Homo sapiens (human)
cellular response to aldosteroneSerine/threonine-protein kinase Sgk1Homo sapiens (human)
peptidyl-serine phosphorylationSerine/threonine-protein kinase Sgk1Homo sapiens (human)
neuron projection morphogenesisSerine/threonine-protein kinase Sgk1Homo sapiens (human)
intracellular signal transductionSerine/threonine-protein kinase Sgk1Homo sapiens (human)
cell surface receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell population proliferationEpidermal growth factor receptorHomo sapiens (human)
MAPK cascadeEpidermal growth factor receptorHomo sapiens (human)
ossificationEpidermal growth factor receptorHomo sapiens (human)
embryonic placenta developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of protein phosphorylationEpidermal growth factor receptorHomo sapiens (human)
hair follicle developmentEpidermal growth factor receptorHomo sapiens (human)
translationEpidermal growth factor receptorHomo sapiens (human)
signal transductionEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
activation of phospholipase C activityEpidermal growth factor receptorHomo sapiens (human)
salivary gland morphogenesisEpidermal growth factor receptorHomo sapiens (human)
midgut developmentEpidermal growth factor receptorHomo sapiens (human)
learning or memoryEpidermal growth factor receptorHomo sapiens (human)
circadian rhythmEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell population proliferationEpidermal growth factor receptorHomo sapiens (human)
diterpenoid metabolic processEpidermal growth factor receptorHomo sapiens (human)
peptidyl-tyrosine phosphorylationEpidermal growth factor receptorHomo sapiens (human)
cerebral cortex cell migrationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell growthEpidermal growth factor receptorHomo sapiens (human)
lung developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell migrationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of superoxide anion generationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationEpidermal growth factor receptorHomo sapiens (human)
response to cobalaminEpidermal growth factor receptorHomo sapiens (human)
response to hydroxyisoflavoneEpidermal growth factor receptorHomo sapiens (human)
cellular response to reactive oxygen speciesEpidermal growth factor receptorHomo sapiens (human)
peptidyl-tyrosine autophosphorylationEpidermal growth factor receptorHomo sapiens (human)
ERBB2-EGFR signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
negative regulation of epidermal growth factor receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
negative regulation of protein catabolic processEpidermal growth factor receptorHomo sapiens (human)
vasodilationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of phosphorylationEpidermal growth factor receptorHomo sapiens (human)
ovulation cycleEpidermal growth factor receptorHomo sapiens (human)
hydrogen peroxide metabolic processEpidermal growth factor receptorHomo sapiens (human)
negative regulation of apoptotic processEpidermal growth factor receptorHomo sapiens (human)
positive regulation of MAP kinase activityEpidermal growth factor receptorHomo sapiens (human)
tongue developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activityEpidermal growth factor receptorHomo sapiens (human)
positive regulation of DNA repairEpidermal growth factor receptorHomo sapiens (human)
positive regulation of DNA replicationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of bone resorptionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of DNA-templated transcriptionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of vasoconstrictionEpidermal growth factor receptorHomo sapiens (human)
negative regulation of mitotic cell cycleEpidermal growth factor receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIEpidermal growth factor receptorHomo sapiens (human)
regulation of JNK cascadeEpidermal growth factor receptorHomo sapiens (human)
symbiont entry into host cellEpidermal growth factor receptorHomo sapiens (human)
protein autophosphorylationEpidermal growth factor receptorHomo sapiens (human)
astrocyte activationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of fibroblast proliferationEpidermal growth factor receptorHomo sapiens (human)
digestive tract morphogenesisEpidermal growth factor receptorHomo sapiens (human)
positive regulation of smooth muscle cell proliferationEpidermal growth factor receptorHomo sapiens (human)
neuron projection morphogenesisEpidermal growth factor receptorHomo sapiens (human)
epithelial cell proliferationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of epithelial cell proliferationEpidermal growth factor receptorHomo sapiens (human)
regulation of peptidyl-tyrosine phosphorylationEpidermal growth factor receptorHomo sapiens (human)
protein insertion into membraneEpidermal growth factor receptorHomo sapiens (human)
response to calcium ionEpidermal growth factor receptorHomo sapiens (human)
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of synaptic transmission, glutamatergicEpidermal growth factor receptorHomo sapiens (human)
positive regulation of glial cell proliferationEpidermal growth factor receptorHomo sapiens (human)
morphogenesis of an epithelial foldEpidermal growth factor receptorHomo sapiens (human)
eyelid development in camera-type eyeEpidermal growth factor receptorHomo sapiens (human)
response to UV-AEpidermal growth factor receptorHomo sapiens (human)
positive regulation of mucus secretionEpidermal growth factor receptorHomo sapiens (human)
regulation of ERK1 and ERK2 cascadeEpidermal growth factor receptorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeEpidermal growth factor receptorHomo sapiens (human)
cellular response to amino acid stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to mechanical stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to cadmium ionEpidermal growth factor receptorHomo sapiens (human)
cellular response to epidermal growth factor stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to estradiol stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to xenobiotic stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to dexamethasone stimulusEpidermal growth factor receptorHomo sapiens (human)
positive regulation of canonical Wnt signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
liver regenerationEpidermal growth factor receptorHomo sapiens (human)
cell-cell adhesionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of protein kinase C activityEpidermal growth factor receptorHomo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleEpidermal growth factor receptorHomo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of prolactin secretionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of miRNA transcriptionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of protein localization to plasma membraneEpidermal growth factor receptorHomo sapiens (human)
negative regulation of cardiocyte differentiationEpidermal growth factor receptorHomo sapiens (human)
neurogenesisEpidermal growth factor receptorHomo sapiens (human)
multicellular organism developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of kinase activityEpidermal growth factor receptorHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
regulation of protein phosphorylationHeat shock protein beta-1Homo sapiens (human)
regulation of translational initiationHeat shock protein beta-1Homo sapiens (human)
negative regulation of protein kinase activityHeat shock protein beta-1Homo sapiens (human)
response to unfolded proteinHeat shock protein beta-1Homo sapiens (human)
response to virusHeat shock protein beta-1Homo sapiens (human)
regulation of autophagyHeat shock protein beta-1Homo sapiens (human)
positive regulation of interleukin-1 beta productionHeat shock protein beta-1Homo sapiens (human)
positive regulation of tumor necrosis factor productionHeat shock protein beta-1Homo sapiens (human)
intracellular signal transductionHeat shock protein beta-1Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulusHeat shock protein beta-1Homo sapiens (human)
negative regulation of apoptotic processHeat shock protein beta-1Homo sapiens (human)
regulation of canonical NF-kappaB signal transductionHeat shock protein beta-1Homo sapiens (human)
positive regulation of blood vessel endothelial cell migrationHeat shock protein beta-1Homo sapiens (human)
positive regulation of angiogenesisHeat shock protein beta-1Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathwayHeat shock protein beta-1Homo sapiens (human)
chaperone-mediated protein foldingHeat shock protein beta-1Homo sapiens (human)
platelet aggregationHeat shock protein beta-1Homo sapiens (human)
anterograde axonal protein transportHeat shock protein beta-1Homo sapiens (human)
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathwayHeat shock protein beta-1Homo sapiens (human)
positive regulation of endothelial cell chemotaxisHeat shock protein beta-1Homo sapiens (human)
response to heatHeat shock protein beta-1Homo sapiens (human)
protein refoldingHeat shock protein beta-1Homo sapiens (human)
steroid catabolic processCytochrome P450 1A2Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A2Homo sapiens (human)
cholesterol metabolic processCytochrome P450 1A2Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A2Homo sapiens (human)
toxin biosynthetic processCytochrome P450 1A2Homo sapiens (human)
post-embryonic developmentCytochrome P450 1A2Homo sapiens (human)
alkaloid metabolic processCytochrome P450 1A2Homo sapiens (human)
regulation of gene expressionCytochrome P450 1A2Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 1A2Homo sapiens (human)
dibenzo-p-dioxin metabolic processCytochrome P450 1A2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
lung developmentCytochrome P450 1A2Homo sapiens (human)
methylationCytochrome P450 1A2Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 1A2Homo sapiens (human)
retinol metabolic processCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A2Homo sapiens (human)
cellular respirationCytochrome P450 1A2Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 1A2Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A2Homo sapiens (human)
oxidative demethylationCytochrome P450 1A2Homo sapiens (human)
cellular response to cadmium ionCytochrome P450 1A2Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
protein phosphorylationTyrosine-protein kinase LckHomo sapiens (human)
intracellular zinc ion homeostasisTyrosine-protein kinase LckHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processTyrosine-protein kinase LckHomo sapiens (human)
response to xenobiotic stimulusTyrosine-protein kinase LckHomo sapiens (human)
peptidyl-tyrosine phosphorylationTyrosine-protein kinase LckHomo sapiens (human)
hemopoiesisTyrosine-protein kinase LckHomo sapiens (human)
platelet activationTyrosine-protein kinase LckHomo sapiens (human)
T cell differentiationTyrosine-protein kinase LckHomo sapiens (human)
T cell costimulationTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of heterotypic cell-cell adhesionTyrosine-protein kinase LckHomo sapiens (human)
intracellular signal transductionTyrosine-protein kinase LckHomo sapiens (human)
peptidyl-tyrosine autophosphorylationTyrosine-protein kinase LckHomo sapiens (human)
Fc-gamma receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
T cell receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of T cell receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of T cell activationTyrosine-protein kinase LckHomo sapiens (human)
leukocyte migrationTyrosine-protein kinase LckHomo sapiens (human)
release of sequestered calcium ion into cytosolTyrosine-protein kinase LckHomo sapiens (human)
regulation of lymphocyte activationTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of leukocyte cell-cell adhesionTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
innate immune responseTyrosine-protein kinase LckHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
B cell receptor signaling pathwayTyrosine-protein kinase LckHomo sapiens (human)
positive regulation of macrophage chemotaxisMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
positive regulation of macrophage proliferationMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
positive regulation of protein phosphorylationMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
response to ischemiaMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
inflammatory responseMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
signal transductionMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
axon guidanceMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
cell population proliferationMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
positive regulation of cell population proliferationMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
negative regulation of cell population proliferationMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
regulation of cell shapeMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
peptidyl-tyrosine phosphorylationMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
cytokine-mediated signaling pathwayMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
olfactory bulb developmentMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
forebrain neuron differentiationMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
hemopoiesisMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
monocyte differentiationMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
macrophage differentiationMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
osteoclast differentiationMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
ruffle organizationMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
positive regulation of chemokine productionMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
regulation of actin cytoskeleton organizationMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
cellular response to macrophage colony-stimulating factor stimulusMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
macrophage colony-stimulating factor signaling pathwayMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
positive regulation of tyrosine phosphorylation of STAT proteinMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
negative regulation of apoptotic processMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
positive regulation by host of viral processMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
innate immune responseMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
regulation of bone resorptionMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
cell-cell junction maintenanceMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
protein autophosphorylationMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
mammary gland duct morphogenesisMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
positive regulation of protein tyrosine kinase activityMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
microglial cell proliferationMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
cellular response to cytokine stimulusMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
regulation of macrophage migrationMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
positive regulation of cell motilityMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
positive regulation of cell migrationMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
regulation of MAPK cascadeMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
positive regulation of kinase activityMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
multicellular organism developmentMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
lipid hydroxylationCytochrome P450 3A4Homo sapiens (human)
lipid metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid catabolic processCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid metabolic processCytochrome P450 3A4Homo sapiens (human)
cholesterol metabolic processCytochrome P450 3A4Homo sapiens (human)
androgen metabolic processCytochrome P450 3A4Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A4Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A4Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 3A4Homo sapiens (human)
calcitriol biosynthetic process from calciolCytochrome P450 3A4Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D metabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D catabolic processCytochrome P450 3A4Homo sapiens (human)
retinol metabolic processCytochrome P450 3A4Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A4Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 3A4Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A4Homo sapiens (human)
oxidative demethylationCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2D6Homo sapiens (human)
steroid metabolic processCytochrome P450 2D6Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2D6Homo sapiens (human)
estrogen metabolic processCytochrome P450 2D6Homo sapiens (human)
coumarin metabolic processCytochrome P450 2D6Homo sapiens (human)
alkaloid metabolic processCytochrome P450 2D6Homo sapiens (human)
alkaloid catabolic processCytochrome P450 2D6Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2D6Homo sapiens (human)
isoquinoline alkaloid metabolic processCytochrome P450 2D6Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2D6Homo sapiens (human)
retinol metabolic processCytochrome P450 2D6Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2D6Homo sapiens (human)
negative regulation of bindingCytochrome P450 2D6Homo sapiens (human)
oxidative demethylationCytochrome P450 2D6Homo sapiens (human)
negative regulation of cellular organofluorine metabolic processCytochrome P450 2D6Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 2D6Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C9 Homo sapiens (human)
steroid metabolic processCytochrome P450 2C9 Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2C9 Homo sapiens (human)
estrogen metabolic processCytochrome P450 2C9 Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C9 Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
urea metabolic processCytochrome P450 2C9 Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 2C9 Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C9 Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
amide metabolic processCytochrome P450 2C9 Homo sapiens (human)
icosanoid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
oxidative demethylationCytochrome P450 2C9 Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
G1/S transition of mitotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
G2/M transition of mitotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICyclin-dependent kinase 2Homo sapiens (human)
DNA replicationCyclin-dependent kinase 2Homo sapiens (human)
DNA repairCyclin-dependent kinase 2Homo sapiens (human)
chromatin remodelingCyclin-dependent kinase 2Homo sapiens (human)
DNA-templated transcriptionCyclin-dependent kinase 2Homo sapiens (human)
protein phosphorylationCyclin-dependent kinase 2Homo sapiens (human)
potassium ion transportCyclin-dependent kinase 2Homo sapiens (human)
centriole replicationCyclin-dependent kinase 2Homo sapiens (human)
Ras protein signal transductionCyclin-dependent kinase 2Homo sapiens (human)
regulation of mitotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of cell population proliferationCyclin-dependent kinase 2Homo sapiens (human)
peptidyl-serine phosphorylationCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of heterochromatin formationCyclin-dependent kinase 2Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of DNA-templated DNA replication initiationCyclin-dependent kinase 2Homo sapiens (human)
telomere maintenance in response to DNA damageCyclin-dependent kinase 2Homo sapiens (human)
post-translational protein modificationCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of DNA replicationCyclin-dependent kinase 2Homo sapiens (human)
positive regulation of DNA-templated transcriptionCyclin-dependent kinase 2Homo sapiens (human)
centrosome duplicationCyclin-dependent kinase 2Homo sapiens (human)
cell divisionCyclin-dependent kinase 2Homo sapiens (human)
meiotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
cellular response to nitric oxideCyclin-dependent kinase 2Homo sapiens (human)
cellular senescenceCyclin-dependent kinase 2Homo sapiens (human)
regulation of anaphase-promoting complex-dependent catabolic processCyclin-dependent kinase 2Homo sapiens (human)
regulation of G2/M transition of mitotic cell cycleCyclin-dependent kinase 2Homo sapiens (human)
signal transductionCyclin-dependent kinase 2Homo sapiens (human)
regulation of gene expressionCyclin-dependent kinase 2Homo sapiens (human)
response to organic substanceCyclin-dependent kinase 2Homo sapiens (human)
long-chain fatty acid metabolic processCytochrome P450 2C19Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C19Homo sapiens (human)
steroid metabolic processCytochrome P450 2C19Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C19Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C19Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C19Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C19Homo sapiens (human)
branching involved in blood vessel morphogenesisVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of macroautophagyVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of mitochondrial depolarizationVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of mitochondrial fissionVascular endothelial growth factor receptor 2Homo sapiens (human)
angiogenesisVascular endothelial growth factor receptor 2Homo sapiens (human)
ovarian follicle developmentVascular endothelial growth factor receptor 2Homo sapiens (human)
vasculogenesisVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of protein phosphorylationVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of endothelial cell proliferationVascular endothelial growth factor receptor 2Homo sapiens (human)
lymph vessel developmentVascular endothelial growth factor receptor 2Homo sapiens (human)
cell migration involved in sprouting angiogenesisVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of mesenchymal cell proliferationVascular endothelial growth factor receptor 2Homo sapiens (human)
epithelial cell maturationVascular endothelial growth factor receptor 2Homo sapiens (human)
endocardium developmentVascular endothelial growth factor receptor 2Homo sapiens (human)
endothelium developmentVascular endothelial growth factor receptor 2Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of cell population proliferationVascular endothelial growth factor receptor 2Homo sapiens (human)
regulation of cell shapeVascular endothelial growth factor receptor 2Homo sapiens (human)
mesenchymal cell proliferationVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of endothelial cell migrationVascular endothelial growth factor receptor 2Homo sapiens (human)
negative regulation of gene expressionVascular endothelial growth factor receptor 2Homo sapiens (human)
peptidyl-tyrosine phosphorylationVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of cell migrationVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of BMP signaling pathwayVascular endothelial growth factor receptor 2Homo sapiens (human)
embryonic hemopoiesisVascular endothelial growth factor receptor 2Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulusVascular endothelial growth factor receptor 2Homo sapiens (human)
vascular endothelial growth factor receptor-2 signaling pathwayVascular endothelial growth factor receptor 2Homo sapiens (human)
peptidyl-tyrosine autophosphorylationVascular endothelial growth factor receptor 2Homo sapiens (human)
vascular endothelial growth factor signaling pathwayVascular endothelial growth factor receptor 2Homo sapiens (human)
surfactant homeostasisVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of MAPK cascadeVascular endothelial growth factor receptor 2Homo sapiens (human)
negative regulation of neuron apoptotic processVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of blood vessel endothelial cell migrationVascular endothelial growth factor receptor 2Homo sapiens (human)
cell fate commitmentVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of angiogenesisVascular endothelial growth factor receptor 2Homo sapiens (human)
protein autophosphorylationVascular endothelial growth factor receptor 2Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathwayVascular endothelial growth factor receptor 2Homo sapiens (human)
lung alveolus developmentVascular endothelial growth factor receptor 2Homo sapiens (human)
post-embryonic camera-type eye morphogenesisVascular endothelial growth factor receptor 2Homo sapiens (human)
epithelial cell proliferationVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of positive chemotaxisVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of nitric-oxide synthase biosynthetic processVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of focal adhesion assemblyVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionVascular endothelial growth factor receptor 2Homo sapiens (human)
calcium ion homeostasisVascular endothelial growth factor receptor 2Homo sapiens (human)
blood vessel endothelial cell differentiationVascular endothelial growth factor receptor 2Homo sapiens (human)
vascular wound healingVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeVascular endothelial growth factor receptor 2Homo sapiens (human)
semaphorin-plexin signaling pathwayVascular endothelial growth factor receptor 2Homo sapiens (human)
stem cell proliferationVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisVascular endothelial growth factor receptor 2Homo sapiens (human)
regulation of hematopoietic progenitor cell differentiationVascular endothelial growth factor receptor 2Homo sapiens (human)
regulation of bone developmentVascular endothelial growth factor receptor 2Homo sapiens (human)
cellular response to hydrogen sulfideVascular endothelial growth factor receptor 2Homo sapiens (human)
negative regulation of endothelial cell apoptotic processVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of stem cell proliferationVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of endothelial cell chemotaxisVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of vasculogenesisVascular endothelial growth factor receptor 2Homo sapiens (human)
regulation of MAPK cascadeVascular endothelial growth factor receptor 2Homo sapiens (human)
multicellular organism developmentVascular endothelial growth factor receptor 2Homo sapiens (human)
cell migrationVascular endothelial growth factor receptor 2Homo sapiens (human)
endothelial cell differentiationVascular endothelial growth factor receptor 2Homo sapiens (human)
positive regulation of kinase activityVascular endothelial growth factor receptor 2Homo sapiens (human)
establishment of protein localizationSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic sister chromatid segregationSerine/threonine-protein kinase PLK1Homo sapiens (human)
G2/M transition of mitotic cell cycleSerine/threonine-protein kinase PLK1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IISerine/threonine-protein kinase PLK1Homo sapiens (human)
establishment of mitotic spindle orientationSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic cell cycleSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic cytokinesisSerine/threonine-protein kinase PLK1Homo sapiens (human)
microtubule bundle formationSerine/threonine-protein kinase PLK1Homo sapiens (human)
double-strand break repairSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein phosphorylationSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic spindle organizationSerine/threonine-protein kinase PLK1Homo sapiens (human)
sister chromatid cohesionSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic chromosome condensationSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic nuclear membrane disassemblySerine/threonine-protein kinase PLK1Homo sapiens (human)
metaphase/anaphase transition of mitotic cell cycleSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic spindle assembly checkpoint signalingSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic G2 DNA damage checkpoint signalingSerine/threonine-protein kinase PLK1Homo sapiens (human)
centrosome cycleSerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of mitotic cell cycleSerine/threonine-protein kinase PLK1Homo sapiens (human)
positive regulation of peptidyl-threonine phosphorylationSerine/threonine-protein kinase PLK1Homo sapiens (human)
female meiosis chromosome segregationSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein ubiquitinationSerine/threonine-protein kinase PLK1Homo sapiens (human)
peptidyl-serine phosphorylationSerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of mitotic metaphase/anaphase transitionSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein destabilizationSerine/threonine-protein kinase PLK1Homo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic processSerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of cytokinesisSerine/threonine-protein kinase PLK1Homo sapiens (human)
negative regulation of apoptotic processSerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of protein bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
homologous chromosome segregationSerine/threonine-protein kinase PLK1Homo sapiens (human)
negative regulation of cyclin-dependent protein serine/threonine kinase activitySerine/threonine-protein kinase PLK1Homo sapiens (human)
positive regulation of proteolysisSerine/threonine-protein kinase PLK1Homo sapiens (human)
Golgi inheritanceSerine/threonine-protein kinase PLK1Homo sapiens (human)
nuclear membrane disassemblySerine/threonine-protein kinase PLK1Homo sapiens (human)
positive regulation of ubiquitin-protein transferase activitySerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of cell cycleSerine/threonine-protein kinase PLK1Homo sapiens (human)
synaptonemal complex disassemblySerine/threonine-protein kinase PLK1Homo sapiens (human)
protein localization to chromatinSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein localization to nuclear envelopeSerine/threonine-protein kinase PLK1Homo sapiens (human)
double-strand break repair via alternative nonhomologous end joiningSerine/threonine-protein kinase PLK1Homo sapiens (human)
positive regulation of protein localization to nucleusSerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of mitotic spindle assemblySerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of mitotic cell cycle phase transitionSerine/threonine-protein kinase PLK1Homo sapiens (human)
positive regulation of ubiquitin protein ligase activitySerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of protein localization to cell cortexSerine/threonine-protein kinase PLK1Homo sapiens (human)
regulation of anaphase-promoting complex-dependent catabolic processSerine/threonine-protein kinase PLK1Homo sapiens (human)
negative regulation of double-strand break repair via homologous recombinationSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein phosphorylationMitogen-activated protein kinase 10Homo sapiens (human)
signal transductionMitogen-activated protein kinase 10Homo sapiens (human)
JNK cascadeMitogen-activated protein kinase 10Homo sapiens (human)
response to light stimulusMitogen-activated protein kinase 10Homo sapiens (human)
Fc-epsilon receptor signaling pathwayMitogen-activated protein kinase 10Homo sapiens (human)
regulation of circadian rhythmMitogen-activated protein kinase 10Homo sapiens (human)
rhythmic processMitogen-activated protein kinase 10Homo sapiens (human)
cellular senescenceMitogen-activated protein kinase 10Homo sapiens (human)
chemotaxisDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
signal transductionDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
heart developmentDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
negative regulation of cell population proliferationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
positive regulation of gene expressionDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
Schwann cell developmentDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
cerebellar cortex formationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
keratinocyte differentiationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
thyroid gland developmentDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
regulation of stress-activated MAPK cascadeDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
endodermal cell differentiationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
ERBB2-ERBB3 signaling pathwayDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
myelinationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
type B pancreatic cell proliferationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
positive regulation of DNA-templated transcriptionDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
insulin-like growth factor receptor signaling pathwayDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
thymus developmentDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
regulation of axon regenerationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
cell motilityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
positive regulation of axonogenesisDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
Bergmann glial cell differentiationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
face developmentDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
trachea formationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
epithelial cell proliferation involved in lung morphogenesisDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
placenta blood vessel developmentDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
labyrinthine layer developmentDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
ERK1 and ERK2 cascadeDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
positive regulation of protein serine/threonine kinase activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
regulation of Golgi inheritanceDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
cellular senescenceDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
positive regulation of endodermal cell differentiationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
regulation of early endosome to late endosome transportDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
neuron differentiationDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
MAPK cascadeDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
neural crest cell migrationReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
positive regulation of protein phosphorylationReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
signal transductionReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
epidermal growth factor receptor signaling pathwayReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STATReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
nervous system developmentReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
synapse assemblyReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
heart developmentReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
lactationReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
positive regulation of cell population proliferationReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
negative regulation of cell population proliferationReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
embryonic pattern specificationReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
cell migrationReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
peptidyl-tyrosine phosphorylationReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
central nervous system morphogenesisReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
olfactory bulb interneuron differentiationReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
regulation of cell migrationReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
ERBB4 signaling pathwayReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
ERBB2-ERBB4 signaling pathwayReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
ERBB4-ERBB4 signaling pathwayReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
positive regulation of tyrosine phosphorylation of STAT proteinReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
mitochondrial fragmentation involved in apoptotic processReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
cell fate commitmentReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
positive regulation of DNA-templated transcriptionReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
protein autophosphorylationReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
positive regulation of cardiac muscle cell proliferationReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
mammary gland epithelial cell differentiationReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
mammary gland alveolus developmentReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
cardiac muscle tissue regenerationReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
cellular response to epidermal growth factor stimulusReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
establishment of planar polarity involved in nephron morphogenesisReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
neurotransmitter receptor localization to postsynaptic specialization membraneReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
positive regulation of protein localization to cell surfaceReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
negative regulation of apoptotic processReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
positive regulation of kinase activityReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
multicellular organism developmentReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
neurogenesisReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
positive regulation of erythrocyte differentiationMitogen-activated protein kinase 11Homo sapiens (human)
osteoblast differentiationMitogen-activated protein kinase 11Homo sapiens (human)
positive regulation of gene expressionMitogen-activated protein kinase 11Homo sapiens (human)
stress-activated protein kinase signaling cascadeMitogen-activated protein kinase 11Homo sapiens (human)
positive regulation of interleukin-12 productionMitogen-activated protein kinase 11Homo sapiens (human)
p38MAPK cascadeMitogen-activated protein kinase 11Homo sapiens (human)
positive regulation of muscle cell differentiationMitogen-activated protein kinase 11Homo sapiens (human)
stress-activated MAPK cascadeMitogen-activated protein kinase 11Homo sapiens (human)
cardiac muscle cell proliferationMitogen-activated protein kinase 11Homo sapiens (human)
negative regulation of cardiac muscle cell proliferationMitogen-activated protein kinase 11Homo sapiens (human)
bone developmentMitogen-activated protein kinase 11Homo sapiens (human)
cellular response to interleukin-1Mitogen-activated protein kinase 11Homo sapiens (human)
cellular response to UV-BMitogen-activated protein kinase 11Homo sapiens (human)
cellular senescenceMitogen-activated protein kinase 11Homo sapiens (human)
cellular response to virusMitogen-activated protein kinase 11Homo sapiens (human)
intracellular signal transductionMitogen-activated protein kinase 11Homo sapiens (human)
positive regulation of blood vessel endothelial cell migrationMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to lipopolysaccharideMitogen-activated protein kinase 14Homo sapiens (human)
DNA damage checkpoint signalingMitogen-activated protein kinase 14Homo sapiens (human)
cell morphogenesisMitogen-activated protein kinase 14Homo sapiens (human)
cartilage condensationMitogen-activated protein kinase 14Homo sapiens (human)
angiogenesisMitogen-activated protein kinase 14Homo sapiens (human)
osteoblast differentiationMitogen-activated protein kinase 14Homo sapiens (human)
placenta developmentMitogen-activated protein kinase 14Homo sapiens (human)
response to dietary excessMitogen-activated protein kinase 14Homo sapiens (human)
chondrocyte differentiationMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusMitogen-activated protein kinase 14Homo sapiens (human)
glucose metabolic processMitogen-activated protein kinase 14Homo sapiens (human)
regulation of transcription by RNA polymerase IIMitogen-activated protein kinase 14Homo sapiens (human)
transcription by RNA polymerase IIMitogen-activated protein kinase 14Homo sapiens (human)
apoptotic processMitogen-activated protein kinase 14Homo sapiens (human)
chemotaxisMitogen-activated protein kinase 14Homo sapiens (human)
signal transductionMitogen-activated protein kinase 14Homo sapiens (human)
cell surface receptor signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
cell surface receptor protein serine/threonine kinase signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
skeletal muscle tissue developmentMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of gene expressionMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of myotube differentiationMitogen-activated protein kinase 14Homo sapiens (human)
peptidyl-serine phosphorylationMitogen-activated protein kinase 14Homo sapiens (human)
fatty acid oxidationMitogen-activated protein kinase 14Homo sapiens (human)
platelet activationMitogen-activated protein kinase 14Homo sapiens (human)
regulation of ossificationMitogen-activated protein kinase 14Homo sapiens (human)
osteoclast differentiationMitogen-activated protein kinase 14Homo sapiens (human)
stress-activated protein kinase signaling cascadeMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of cyclase activityMitogen-activated protein kinase 14Homo sapiens (human)
lipopolysaccharide-mediated signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
response to muramyl dipeptideMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of interleukin-12 productionMitogen-activated protein kinase 14Homo sapiens (human)
response to insulinMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of hippo signalingMitogen-activated protein kinase 14Homo sapiens (human)
intracellular signal transductionMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulusMitogen-activated protein kinase 14Homo sapiens (human)
response to muscle stretchMitogen-activated protein kinase 14Homo sapiens (human)
p38MAPK cascadeMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of protein import into nucleusMitogen-activated protein kinase 14Homo sapiens (human)
signal transduction in response to DNA damageMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of erythrocyte differentiationMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of myoblast differentiationMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIMitogen-activated protein kinase 14Homo sapiens (human)
glucose importMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of glucose importMitogen-activated protein kinase 14Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
stem cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
striated muscle cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of muscle cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
stress-activated MAPK cascadeMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of cardiac muscle cell proliferationMitogen-activated protein kinase 14Homo sapiens (human)
bone developmentMitogen-activated protein kinase 14Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to lipoteichoic acidMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to tumor necrosis factorMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to ionizing radiationMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to UV-BMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of canonical Wnt signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of brown fat cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
cellular senescenceMitogen-activated protein kinase 14Homo sapiens (human)
stress-induced premature senescenceMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to virusMitogen-activated protein kinase 14Homo sapiens (human)
regulation of synaptic membrane adhesionMitogen-activated protein kinase 14Homo sapiens (human)
regulation of cytokine production involved in inflammatory responseMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of myoblast fusionMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processMitogen-activated protein kinase 14Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (111)

Processvia Protein(s)Taxonomy
protein serine/threonine kinase activitySerine/threonine-protein kinase Sgk1Homo sapiens (human)
protein serine/threonine/tyrosine kinase activitySerine/threonine-protein kinase Sgk1Homo sapiens (human)
calcium channel regulator activitySerine/threonine-protein kinase Sgk1Homo sapiens (human)
protein bindingSerine/threonine-protein kinase Sgk1Homo sapiens (human)
ATP bindingSerine/threonine-protein kinase Sgk1Homo sapiens (human)
potassium channel regulator activitySerine/threonine-protein kinase Sgk1Homo sapiens (human)
sodium channel regulator activitySerine/threonine-protein kinase Sgk1Homo sapiens (human)
chloride channel regulator activitySerine/threonine-protein kinase Sgk1Homo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase Sgk1Homo sapiens (human)
epidermal growth factor receptor activityEpidermal growth factor receptorHomo sapiens (human)
virus receptor activityEpidermal growth factor receptorHomo sapiens (human)
chromatin bindingEpidermal growth factor receptorHomo sapiens (human)
double-stranded DNA bindingEpidermal growth factor receptorHomo sapiens (human)
MAP kinase kinase kinase activityEpidermal growth factor receptorHomo sapiens (human)
protein tyrosine kinase activityEpidermal growth factor receptorHomo sapiens (human)
transmembrane receptor protein tyrosine kinase activityEpidermal growth factor receptorHomo sapiens (human)
transmembrane signaling receptor activityEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor receptor activityEpidermal growth factor receptorHomo sapiens (human)
integrin bindingEpidermal growth factor receptorHomo sapiens (human)
protein bindingEpidermal growth factor receptorHomo sapiens (human)
calmodulin bindingEpidermal growth factor receptorHomo sapiens (human)
ATP bindingEpidermal growth factor receptorHomo sapiens (human)
enzyme bindingEpidermal growth factor receptorHomo sapiens (human)
kinase bindingEpidermal growth factor receptorHomo sapiens (human)
protein kinase bindingEpidermal growth factor receptorHomo sapiens (human)
protein phosphatase bindingEpidermal growth factor receptorHomo sapiens (human)
protein tyrosine kinase activator activityEpidermal growth factor receptorHomo sapiens (human)
transmembrane receptor protein tyrosine kinase activator activityEpidermal growth factor receptorHomo sapiens (human)
ubiquitin protein ligase bindingEpidermal growth factor receptorHomo sapiens (human)
identical protein bindingEpidermal growth factor receptorHomo sapiens (human)
cadherin bindingEpidermal growth factor receptorHomo sapiens (human)
actin filament bindingEpidermal growth factor receptorHomo sapiens (human)
ATPase bindingEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor bindingEpidermal growth factor receptorHomo sapiens (human)
RNA bindingHeat shock protein beta-1Homo sapiens (human)
protein kinase C bindingHeat shock protein beta-1Homo sapiens (human)
protein bindingHeat shock protein beta-1Homo sapiens (human)
protein kinase C inhibitor activityHeat shock protein beta-1Homo sapiens (human)
protein kinase bindingHeat shock protein beta-1Homo sapiens (human)
identical protein bindingHeat shock protein beta-1Homo sapiens (human)
protein homodimerization activityHeat shock protein beta-1Homo sapiens (human)
ubiquitin bindingHeat shock protein beta-1Homo sapiens (human)
protein folding chaperoneHeat shock protein beta-1Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingHeat shock protein beta-1Homo sapiens (human)
unfolded protein bindingHeat shock protein beta-1Homo sapiens (human)
monooxygenase activityCytochrome P450 1A2Homo sapiens (human)
iron ion bindingCytochrome P450 1A2Homo sapiens (human)
protein bindingCytochrome P450 1A2Homo sapiens (human)
electron transfer activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1A2Homo sapiens (human)
enzyme bindingCytochrome P450 1A2Homo sapiens (human)
heme bindingCytochrome P450 1A2Homo sapiens (human)
demethylase activityCytochrome P450 1A2Homo sapiens (human)
caffeine oxidase activityCytochrome P450 1A2Homo sapiens (human)
aromatase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A2Homo sapiens (human)
phosphotyrosine residue bindingTyrosine-protein kinase LckHomo sapiens (human)
protein tyrosine kinase activityTyrosine-protein kinase LckHomo sapiens (human)
non-membrane spanning protein tyrosine kinase activityTyrosine-protein kinase LckHomo sapiens (human)
protein serine/threonine phosphatase activityTyrosine-protein kinase LckHomo sapiens (human)
protein bindingTyrosine-protein kinase LckHomo sapiens (human)
ATP bindingTyrosine-protein kinase LckHomo sapiens (human)
phospholipase activator activityTyrosine-protein kinase LckHomo sapiens (human)
protein kinase bindingTyrosine-protein kinase LckHomo sapiens (human)
protein phosphatase bindingTyrosine-protein kinase LckHomo sapiens (human)
SH2 domain bindingTyrosine-protein kinase LckHomo sapiens (human)
T cell receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
CD4 receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
CD8 receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
identical protein bindingTyrosine-protein kinase LckHomo sapiens (human)
phospholipase bindingTyrosine-protein kinase LckHomo sapiens (human)
phosphatidylinositol 3-kinase bindingTyrosine-protein kinase LckHomo sapiens (human)
ATPase bindingTyrosine-protein kinase LckHomo sapiens (human)
signaling receptor bindingTyrosine-protein kinase LckHomo sapiens (human)
protein tyrosine kinase activityMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
macrophage colony-stimulating factor receptor activityMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
protein bindingMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
ATP bindingMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
protein phosphatase bindingMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
cytokine bindingMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
protein homodimerization activityMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
growth factor bindingMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
steroid bindingCytochrome P450 3A4Homo sapiens (human)
iron ion bindingCytochrome P450 3A4Homo sapiens (human)
protein bindingCytochrome P450 3A4Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A4Homo sapiens (human)
oxygen bindingCytochrome P450 3A4Homo sapiens (human)
enzyme bindingCytochrome P450 3A4Homo sapiens (human)
heme bindingCytochrome P450 3A4Homo sapiens (human)
vitamin D3 25-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
caffeine oxidase activityCytochrome P450 3A4Homo sapiens (human)
quinine 3-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
aromatase activityCytochrome P450 3A4Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1,8-cineole 2-exo-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
monooxygenase activityCytochrome P450 2D6Homo sapiens (human)
iron ion bindingCytochrome P450 2D6Homo sapiens (human)
oxidoreductase activityCytochrome P450 2D6Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2D6Homo sapiens (human)
heme bindingCytochrome P450 2D6Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
iron ion bindingCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 14,15-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 11,12-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
caffeine oxidase activityCytochrome P450 2C9 Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
aromatase activityCytochrome P450 2C9 Homo sapiens (human)
heme bindingCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C9 Homo sapiens (human)
histone kinase activityCyclin-dependent kinase 2Homo sapiens (human)
magnesium ion bindingCyclin-dependent kinase 2Homo sapiens (human)
protein serine/threonine kinase activityCyclin-dependent kinase 2Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activityCyclin-dependent kinase 2Homo sapiens (human)
protein bindingCyclin-dependent kinase 2Homo sapiens (human)
ATP bindingCyclin-dependent kinase 2Homo sapiens (human)
protein domain specific bindingCyclin-dependent kinase 2Homo sapiens (human)
cyclin bindingCyclin-dependent kinase 2Homo sapiens (human)
cyclin-dependent protein kinase activityCyclin-dependent kinase 2Homo sapiens (human)
protein serine kinase activityCyclin-dependent kinase 2Homo sapiens (human)
monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
iron ion bindingCytochrome P450 2C19Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C19Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C19Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
oxygen bindingCytochrome P450 2C19Homo sapiens (human)
enzyme bindingCytochrome P450 2C19Homo sapiens (human)
heme bindingCytochrome P450 2C19Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
aromatase activityCytochrome P450 2C19Homo sapiens (human)
long-chain fatty acid omega-1 hydroxylase activityCytochrome P450 2C19Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C19Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C19Homo sapiens (human)
protein tyrosine kinase activityVascular endothelial growth factor receptor 2Homo sapiens (human)
transmembrane receptor protein tyrosine kinase activityVascular endothelial growth factor receptor 2Homo sapiens (human)
vascular endothelial growth factor receptor activityVascular endothelial growth factor receptor 2Homo sapiens (human)
integrin bindingVascular endothelial growth factor receptor 2Homo sapiens (human)
protein bindingVascular endothelial growth factor receptor 2Homo sapiens (human)
ATP bindingVascular endothelial growth factor receptor 2Homo sapiens (human)
coreceptor activityVascular endothelial growth factor receptor 2Homo sapiens (human)
growth factor bindingVascular endothelial growth factor receptor 2Homo sapiens (human)
vascular endothelial growth factor bindingVascular endothelial growth factor receptor 2Homo sapiens (human)
identical protein bindingVascular endothelial growth factor receptor 2Homo sapiens (human)
cadherin bindingVascular endothelial growth factor receptor 2Homo sapiens (human)
Hsp90 protein bindingVascular endothelial growth factor receptor 2Homo sapiens (human)
magnesium ion bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein kinase activitySerine/threonine-protein kinase PLK1Homo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase PLK1Homo sapiens (human)
protein bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
ATP bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
microtubule bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
anaphase-promoting complex bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein kinase bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
identical protein bindingSerine/threonine-protein kinase PLK1Homo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase PLK1Homo sapiens (human)
JUN kinase activityMitogen-activated protein kinase 10Homo sapiens (human)
MAP kinase kinase activityMitogen-activated protein kinase 10Homo sapiens (human)
protein bindingMitogen-activated protein kinase 10Homo sapiens (human)
ATP bindingMitogen-activated protein kinase 10Homo sapiens (human)
protein serine kinase activityMitogen-activated protein kinase 10Homo sapiens (human)
protein kinase activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
protein serine/threonine kinase activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
MAP kinase kinase activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
protein serine/threonine/tyrosine kinase activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
protein tyrosine kinase activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
MAP-kinase scaffold activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
protein bindingDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
ATP bindingDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
protein kinase activator activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
protein serine/threonine kinase activator activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
scaffold protein bindingDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
protein serine kinase activityDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
transcription cis-regulatory region bindingReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
protein tyrosine kinase activityReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
transmembrane receptor protein tyrosine kinase activityReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
epidermal growth factor receptor activityReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
epidermal growth factor receptor bindingReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
protein bindingReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
ATP bindingReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
neuregulin receptor activityReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
protein homodimerization activityReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
GABA receptor bindingReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
protein serine/threonine kinase activityMitogen-activated protein kinase 11Homo sapiens (human)
MAP kinase activityMitogen-activated protein kinase 11Homo sapiens (human)
protein bindingMitogen-activated protein kinase 11Homo sapiens (human)
ATP bindingMitogen-activated protein kinase 11Homo sapiens (human)
protein serine kinase activityMitogen-activated protein kinase 11Homo sapiens (human)
protein serine/threonine kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
MAP kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
MAP kinase kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
protein bindingMitogen-activated protein kinase 14Homo sapiens (human)
ATP bindingMitogen-activated protein kinase 14Homo sapiens (human)
enzyme bindingMitogen-activated protein kinase 14Homo sapiens (human)
protein phosphatase bindingMitogen-activated protein kinase 14Homo sapiens (human)
mitogen-activated protein kinase p38 bindingMitogen-activated protein kinase 14Homo sapiens (human)
NFAT protein bindingMitogen-activated protein kinase 14Homo sapiens (human)
protein serine kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (84)

Processvia Protein(s)Taxonomy
nucleoplasmSerine/threonine-protein kinase Sgk1Homo sapiens (human)
mitochondrionSerine/threonine-protein kinase Sgk1Homo sapiens (human)
endoplasmic reticulum membraneSerine/threonine-protein kinase Sgk1Homo sapiens (human)
cytosolSerine/threonine-protein kinase Sgk1Homo sapiens (human)
plasma membraneSerine/threonine-protein kinase Sgk1Homo sapiens (human)
nuclear speckSerine/threonine-protein kinase Sgk1Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase Sgk1Homo sapiens (human)
nucleusSerine/threonine-protein kinase Sgk1Homo sapiens (human)
endosomeEpidermal growth factor receptorHomo sapiens (human)
plasma membraneEpidermal growth factor receptorHomo sapiens (human)
ruffle membraneEpidermal growth factor receptorHomo sapiens (human)
Golgi membraneEpidermal growth factor receptorHomo sapiens (human)
extracellular spaceEpidermal growth factor receptorHomo sapiens (human)
nucleusEpidermal growth factor receptorHomo sapiens (human)
cytoplasmEpidermal growth factor receptorHomo sapiens (human)
endosomeEpidermal growth factor receptorHomo sapiens (human)
endoplasmic reticulum membraneEpidermal growth factor receptorHomo sapiens (human)
plasma membraneEpidermal growth factor receptorHomo sapiens (human)
focal adhesionEpidermal growth factor receptorHomo sapiens (human)
cell surfaceEpidermal growth factor receptorHomo sapiens (human)
endosome membraneEpidermal growth factor receptorHomo sapiens (human)
membraneEpidermal growth factor receptorHomo sapiens (human)
basolateral plasma membraneEpidermal growth factor receptorHomo sapiens (human)
apical plasma membraneEpidermal growth factor receptorHomo sapiens (human)
cell junctionEpidermal growth factor receptorHomo sapiens (human)
clathrin-coated endocytic vesicle membraneEpidermal growth factor receptorHomo sapiens (human)
early endosome membraneEpidermal growth factor receptorHomo sapiens (human)
nuclear membraneEpidermal growth factor receptorHomo sapiens (human)
membrane raftEpidermal growth factor receptorHomo sapiens (human)
perinuclear region of cytoplasmEpidermal growth factor receptorHomo sapiens (human)
multivesicular body, internal vesicle lumenEpidermal growth factor receptorHomo sapiens (human)
intracellular vesicleEpidermal growth factor receptorHomo sapiens (human)
protein-containing complexEpidermal growth factor receptorHomo sapiens (human)
receptor complexEpidermal growth factor receptorHomo sapiens (human)
Shc-EGFR complexEpidermal growth factor receptorHomo sapiens (human)
basal plasma membraneEpidermal growth factor receptorHomo sapiens (human)
cornified envelopeHeat shock protein beta-1Homo sapiens (human)
extracellular spaceHeat shock protein beta-1Homo sapiens (human)
nucleusHeat shock protein beta-1Homo sapiens (human)
cytoplasmHeat shock protein beta-1Homo sapiens (human)
spindleHeat shock protein beta-1Homo sapiens (human)
cytosolHeat shock protein beta-1Homo sapiens (human)
cytoskeletonHeat shock protein beta-1Homo sapiens (human)
focal adhesionHeat shock protein beta-1Homo sapiens (human)
Z discHeat shock protein beta-1Homo sapiens (human)
extracellular exosomeHeat shock protein beta-1Homo sapiens (human)
axon cytoplasmHeat shock protein beta-1Homo sapiens (human)
proteasome complexHeat shock protein beta-1Homo sapiens (human)
cytoplasmHeat shock protein beta-1Homo sapiens (human)
nucleusHeat shock protein beta-1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
pericentriolar materialTyrosine-protein kinase LckHomo sapiens (human)
immunological synapseTyrosine-protein kinase LckHomo sapiens (human)
cytosolTyrosine-protein kinase LckHomo sapiens (human)
plasma membraneTyrosine-protein kinase LckHomo sapiens (human)
membrane raftTyrosine-protein kinase LckHomo sapiens (human)
extracellular exosomeTyrosine-protein kinase LckHomo sapiens (human)
plasma membraneTyrosine-protein kinase LckHomo sapiens (human)
nucleoplasmMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
plasma membraneMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
cell surfaceMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
intracellular membrane-bounded organelleMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
CSF1-CSF1R complexMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
receptor complexMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
plasma membraneMacrophage colony-stimulating factor 1 receptorHomo sapiens (human)
cytoplasmCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A4Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A4Homo sapiens (human)
mitochondrionCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulumCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2D6Homo sapiens (human)
cytoplasmCytochrome P450 2D6Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C9 Homo sapiens (human)
plasma membraneCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
cytoplasmCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
chromosome, telomeric regionCyclin-dependent kinase 2Homo sapiens (human)
condensed chromosomeCyclin-dependent kinase 2Homo sapiens (human)
X chromosomeCyclin-dependent kinase 2Homo sapiens (human)
Y chromosomeCyclin-dependent kinase 2Homo sapiens (human)
male germ cell nucleusCyclin-dependent kinase 2Homo sapiens (human)
nucleusCyclin-dependent kinase 2Homo sapiens (human)
nuclear envelopeCyclin-dependent kinase 2Homo sapiens (human)
nucleoplasmCyclin-dependent kinase 2Homo sapiens (human)
cytoplasmCyclin-dependent kinase 2Homo sapiens (human)
endosomeCyclin-dependent kinase 2Homo sapiens (human)
centrosomeCyclin-dependent kinase 2Homo sapiens (human)
cytosolCyclin-dependent kinase 2Homo sapiens (human)
Cajal bodyCyclin-dependent kinase 2Homo sapiens (human)
cyclin A1-CDK2 complexCyclin-dependent kinase 2Homo sapiens (human)
cyclin A2-CDK2 complexCyclin-dependent kinase 2Homo sapiens (human)
cyclin E1-CDK2 complexCyclin-dependent kinase 2Homo sapiens (human)
cyclin E2-CDK2 complexCyclin-dependent kinase 2Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complexCyclin-dependent kinase 2Homo sapiens (human)
transcription regulator complexCyclin-dependent kinase 2Homo sapiens (human)
cytoplasmCyclin-dependent kinase 2Homo sapiens (human)
nucleusCyclin-dependent kinase 2Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C19Homo sapiens (human)
plasma membraneCytochrome P450 2C19Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C19Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C19Homo sapiens (human)
cytoplasmCytochrome P450 2C19Homo sapiens (human)
extracellular regionVascular endothelial growth factor receptor 2Homo sapiens (human)
nucleusVascular endothelial growth factor receptor 2Homo sapiens (human)
endosomeVascular endothelial growth factor receptor 2Homo sapiens (human)
early endosomeVascular endothelial growth factor receptor 2Homo sapiens (human)
endoplasmic reticulumVascular endothelial growth factor receptor 2Homo sapiens (human)
Golgi apparatusVascular endothelial growth factor receptor 2Homo sapiens (human)
plasma membraneVascular endothelial growth factor receptor 2Homo sapiens (human)
external side of plasma membraneVascular endothelial growth factor receptor 2Homo sapiens (human)
cell junctionVascular endothelial growth factor receptor 2Homo sapiens (human)
membrane raftVascular endothelial growth factor receptor 2Homo sapiens (human)
anchoring junctionVascular endothelial growth factor receptor 2Homo sapiens (human)
sorting endosomeVascular endothelial growth factor receptor 2Homo sapiens (human)
plasma membraneVascular endothelial growth factor receptor 2Homo sapiens (human)
receptor complexVascular endothelial growth factor receptor 2Homo sapiens (human)
spindle microtubuleSerine/threonine-protein kinase PLK1Homo sapiens (human)
kinetochoreSerine/threonine-protein kinase PLK1Homo sapiens (human)
synaptonemal complexSerine/threonine-protein kinase PLK1Homo sapiens (human)
spindle poleSerine/threonine-protein kinase PLK1Homo sapiens (human)
nucleusSerine/threonine-protein kinase PLK1Homo sapiens (human)
nucleoplasmSerine/threonine-protein kinase PLK1Homo sapiens (human)
centrosomeSerine/threonine-protein kinase PLK1Homo sapiens (human)
centrioleSerine/threonine-protein kinase PLK1Homo sapiens (human)
spindleSerine/threonine-protein kinase PLK1Homo sapiens (human)
cytosolSerine/threonine-protein kinase PLK1Homo sapiens (human)
microtubule cytoskeletonSerine/threonine-protein kinase PLK1Homo sapiens (human)
midbodySerine/threonine-protein kinase PLK1Homo sapiens (human)
centriolar satelliteSerine/threonine-protein kinase PLK1Homo sapiens (human)
spindle midzoneSerine/threonine-protein kinase PLK1Homo sapiens (human)
mitotic spindle poleSerine/threonine-protein kinase PLK1Homo sapiens (human)
chromatinSerine/threonine-protein kinase PLK1Homo sapiens (human)
outer kinetochoreSerine/threonine-protein kinase PLK1Homo sapiens (human)
nucleusSerine/threonine-protein kinase PLK1Homo sapiens (human)
centrosomeSerine/threonine-protein kinase PLK1Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase PLK1Homo sapiens (human)
spindle poleSerine/threonine-protein kinase PLK1Homo sapiens (human)
kinetochoreSerine/threonine-protein kinase PLK1Homo sapiens (human)
nucleoplasmMitogen-activated protein kinase 10Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 10Homo sapiens (human)
mitochondrionMitogen-activated protein kinase 10Homo sapiens (human)
cytosolMitogen-activated protein kinase 10Homo sapiens (human)
plasma membraneMitogen-activated protein kinase 10Homo sapiens (human)
nucleusMitogen-activated protein kinase 10Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 10Homo sapiens (human)
nucleusDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
mitochondrionDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
early endosomeDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
late endosomeDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
endoplasmic reticulumDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
Golgi apparatusDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
centrosomeDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
cytosolDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
plasma membraneDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
focal adhesionDual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)
plasma membraneReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
extracellular regionReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
nucleusReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
nucleoplasmReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
mitochondrionReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
mitochondrial matrixReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
cytosolReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
plasma membraneReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
basolateral plasma membraneReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
neuromuscular junctionReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
presynaptic membraneReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
postsynaptic membraneReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
postsynaptic density membraneReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
glutamatergic synapseReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
GABA-ergic synapseReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
receptor complexReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
basal plasma membraneReceptor tyrosine-protein kinase erbB-4Homo sapiens (human)
nucleoplasmMitogen-activated protein kinase 11Homo sapiens (human)
cytosolMitogen-activated protein kinase 11Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 11Homo sapiens (human)
nucleusMitogen-activated protein kinase 11Homo sapiens (human)
cytosolMitogen-activated protein kinase 14Homo sapiens (human)
spindle poleMitogen-activated protein kinase 14Homo sapiens (human)
extracellular regionMitogen-activated protein kinase 14Homo sapiens (human)
nucleusMitogen-activated protein kinase 14Homo sapiens (human)
nucleoplasmMitogen-activated protein kinase 14Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 14Homo sapiens (human)
mitochondrionMitogen-activated protein kinase 14Homo sapiens (human)
cytosolMitogen-activated protein kinase 14Homo sapiens (human)
nuclear speckMitogen-activated protein kinase 14Homo sapiens (human)
secretory granule lumenMitogen-activated protein kinase 14Homo sapiens (human)
glutamatergic synapseMitogen-activated protein kinase 14Homo sapiens (human)
ficolin-1-rich granule lumenMitogen-activated protein kinase 14Homo sapiens (human)
nucleusMitogen-activated protein kinase 14Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 14Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (256)

Assay IDTitleYearJournalArticle
AID342130Selectivity for human p38alpha over JNK32008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID389570Binding affinity to human LKB1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390072Binding affinity to human TYK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390057Binding affinity to human EPHA5 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID599583Inhibition of p38alpha-dependent TNFalpha production in human whole blood preincubated for 1 hr before LPS challenge by ELISA2009Journal of medicinal chemistry, Oct-22, Volume: 52, Issue:20
p38alpha mitogen-activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression.
AID389533Binding affinity to human MSK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390080Binding affinity to human RIPK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389596Binding affinity to human CLK4 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389536Binding affinity to human RSK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389633Binding affinity to human GCN2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID342148Inhibition of LPS-stimulated TNF alpha release in human whole blood cells by ELISA2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID390010Binding affinity to human LCK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389601Binding affinity to human CK2A2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID349059Inhibition of EGFR2008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
Kinase array design, back to front: biaryl amides.
AID349063Inhibition of PLK12008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
Kinase array design, back to front: biaryl amides.
AID390064Binding affinity to human EPHB4 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390032Binding affinity to human PDGFRB at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390063Binding affinity to human EPHB3 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID349051Inhibition of LPS-stimulated TNFalpha release in human whole blood2008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
Kinase array design, back to front: biaryl amides.
AID341053Ratio of IC50 for HSP27 phosphorylation to IC50 for p38alpha phosphorylation in IL-1-alpha-stimulated HLF cells2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes.
AID389555Binding affinity to human PHKG1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390045Binding affinity to human AXL at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390003Binding affinity to human ARG at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390026Binding affinity to human KDR at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390058Binding affinity to human EPHA4 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389604Binding affinity to human KHS1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390053Binding affinity to human ERBB4 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390075Binding affinity to human TESK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390018Binding affinity to human CSK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389628Binding affinity to human TLK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390027Binding affinity to human FLT1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390071Binding affinity to human JAK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID599582Inhibition of p38alpha-dependent TNFalpha production in human PBMC preincubated for 1 hr before LPS challenge by ELISA2009Journal of medicinal chemistry, Oct-22, Volume: 52, Issue:20
p38alpha mitogen-activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression.
AID389535Binding affinity to human RSK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389561Binding affinity to human BRSK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389598Binding affinity to human CLK3 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390002Binding affinity to human ABL at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID342125Selectivity for human p38alpha over AKT12008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID390024Binding affinity to human FGFR4 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389615Binding affinity to human LOK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390038Binding affinity to human INSR at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390009Binding affinity to human LYN at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389571Binding affinity to human AURC at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390050Binding affinity to human TNK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389618Binding affinity to human PAK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389550Binding affinity to human CAMK1G at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389603Binding affinity to human MAP3K4 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389585Binding affinity to human ERK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390007Binding affinity to human ITK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389589Binding affinity to human JNK3 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389620Binding affinity to human PAK5 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389608Binding affinity to human TNIK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390012Binding affinity to human SRC at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID342134Inhibition of human recombinant CYP1A2 transfected in Escherichia coli co-expressed with human NADPH reductase2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID342141Volume of distribution at steady state in Lewis rat at 0.5 mg/kg, iv2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID342143Oral bioavailability in Lewis rat at 1.5 mg/kg2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID342123Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID342128Selectivity for human p38alpha over EphB42008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID342138Inhibition of human recombinant CYP2C9 transfected in Escherichia coli co-expressed with human NADPH reductase2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID390023Binding affinity to human FGFR1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID342144Ratio of drug level in brain to plasma in Lewis rat at 0.5 mg/kg, iv and 1.5 mg/kg, po2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID389582Binding affinity to human CDK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389572Binding affinity to human AURB at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389600Binding affinity to human CK2A1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390079Binding affinity to human RAF1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID342133Selectivity for human p38alpha over Syk2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID389558Binding affinity to human STK33 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390033Binding affinity to human FLT3 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID342124Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38beta by fluorescence polarisation assay2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID390081Binding affinity to human CK1a2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390087Binding affinity to human TTK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390078Binding affinity to human BRAF at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390001Binding affinity to human ACTR2B at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389098Binding affinity to human AKT1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389607Binding affinity to human HGK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390066Binding affinity to human EPHA2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID342147Antiinflammatory activity against collagen-induced arthritis in DBA/1 mouse model at 30 mg/kg/day, po for 14 days2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID390034Binding affinity to human TIE2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389636Binding affinity to human ALK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390074Binding affinity to human LIMK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389586Binding affinity to human ERK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389621Binding affinity to human PAK6 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID342139Inhibition of LPS-stimulated TNF alpha release in human PBMC cells by ELISA2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID342136Inhibition of human recombinant CYP2D6 transfected in Escherichia coli co-expressed with human NADPH reductase2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID390068Binding affinity to human FAK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389630Binding affinity to human AAK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389578Binding affinity to human DAPK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID1540358Inhibition of P38alpha MAPK (unknown origin)2019European journal of medicinal chemistry, Nov-15, Volume: 182Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation.
AID389560Binding affinity to human AMPKA2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390036Binding affinity to human LTK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389546Binding affinity to human YANK3 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390011Binding affinity to human BLK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389565Binding affinity to human QIK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389556Binding affinity to human PHKG2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389998Binding affinity to human TGFBR1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389568Binding affinity to human CAMKK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389595Binding affinity to human CLK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389590Binding affinity to human JNK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390014Binding affinity to human FYN at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389610Binding affinity to human MST2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID342140Clearance in Lewis rat plasma at 0.5 mg/kg, iv2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID389614Binding affinity to human SLK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389564Binding affinity to human MARK4 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389597Binding affinity to human CLK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390077Binding affinity to human MLK3 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390055Binding affinity to human ZAP70 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389635Binding affinity to human ALK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389569Binding affinity to human CAMKK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID349061Inhibition of JNK32008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
Kinase array design, back to front: biaryl amides.
AID389554Binding affinity to human CAMK2G at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389567Binding affinity to human PIM2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390061Binding affinity to human EPHB1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390021Binding affinity to human FGFR2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389623Binding affinity to human FUSED at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID349058Inhibition of cFMS2008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
Kinase array design, back to front: biaryl amides.
AID389606Binding affinity to human HPK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389617Binding affinity to human PAK3 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390086Binding affinity to human MPSK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390062Binding affinity to human EPHB2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390030Binding affinity to human KIT at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID342126Selectivity for human p38alpha over Aurora A2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID341193Binding affinity to human unphosphorylated p38alpha by surface plasmon resonance2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes.
AID390031Binding affinity to human PDGFRA at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389627Binding affinity to human NEK7 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389602Binding affinity to human MAP3K5 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389634Binding affinity to human MYT1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390019Binding affinity to human FER at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390015Binding affinity to human FGR at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389553Binding affinity to human CAMK2B at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389581Binding affinity to human SKMLCK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389563Binding affinity to human MARK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389538Binding affinity to human PRKX at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID349056Inhibition of MEK1 by cRaf/mek/Erk cascade assay2008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
Kinase array design, back to front: biaryl amides.
AID389573Binding affinity to human AURA at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389099Binding affinity to human AKT2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390029Binding affinity to human FMS at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389574Binding affinity to human PLK3 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID599584Inhibition of human CYP2C9 expressed in Escherichia coli by fluorimetric assay2009Journal of medicinal chemistry, Oct-22, Volume: 52, Issue:20
p38alpha mitogen-activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression.
AID389280Binding affinity to human PKCA at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390025Binding affinity to human RET at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID342146Antiinflammatory activity against collagen-induced arthritis in DBA/1 mouse model at 15 mg/kg/day, po for 14 days2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID389547Binding affinity to human YANK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID341192Ratio of IC50 for LPS-stimulated TNFalpha release in human PBMC to Ki for human p38alpha2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes.
AID390006Binding affinity to human TXK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID341050Inhibition of human recombinant p38alpha-mediated ATF2 phosphorylation by TR-FRET assay2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes.
AID390005Binding affinity to human BMX at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390049Binding affinity to human ACK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389629Binding affinity to human TLK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390052Binding affinity to human ERBB2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID341052Inhibition of p38alpha phosphorylation in IL-1-alpha-stimulated HLF cells2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes.
AID389575Binding affinity to human PLK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID342132Selectivity for human p38alpha over ROCK12008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID342149Inhibition of human recombinant His-tagged p38alpha-mediated ATF2 phosphorylation by TR-FRET assay2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID390082Binding affinity to human CK1d at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389100Binding affinity to human AKT3 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389545Binding affinity to human PDK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390069Binding affinity to human PYK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389559Binding affinity to human AMPKA1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389999Binding affinity to human BMPR1A at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389551Binding affinity to human CAMK2A at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389541Binding affinity to human PKG2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389584Binding affinity to human PCTAIRE1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389594Binding affinity to human GSK3A at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389583Binding affinity to human CDK5 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390004Binding affinity to human BTK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390088Binding affinity to human ADCK3 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389532Binding affinity to human PKN2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390085Binding affinity to human CK1g2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389531Binding affinity to human PKCH at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID342131Selectivity for human p38alpha over Lck2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID342145Antiinflammatory activity against peptidoglycan polysaccharide-induced arthritis in rat reactivation model after 14 days2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID599580Inhibition of GST-tagged p38alpha by fluorescence polarization method2009Journal of medicinal chemistry, Oct-22, Volume: 52, Issue:20
p38alpha mitogen-activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression.
AID349062Inhibition of LCK2008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
Kinase array design, back to front: biaryl amides.
AID390040Binding affinity to human IRR at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID341049Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes.
AID389534Binding affinity to human MSK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390046Binding affinity to human MER at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390017Binding affinity to human BRK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389562Binding affinity to human MARK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389588Binding affinity to human JNK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390054Binding affinity to human SYK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390056Binding affinity to human EPHA3 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID342135Inhibition of human recombinant CYP2C19 transfected in Escherichia coli co-expressed with human NADPH reductase2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID390008Binding affinity to human HCK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID349057Inhibition of CDK22008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
Kinase array design, back to front: biaryl amides.
AID390020Binding affinity to human FES at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390028Binding affinity to human FLT4 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390076Binding affinity to human HH498 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390043Binding affinity to human TRKA at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389544Binding affinity to human NDR2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390044Binding affinity to human MUSK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390083Binding affinity to human CK1e at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389557Binding affinity to human MNK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389609Binding affinity to human MST1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389632Binding affinity to human GAK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389619Binding affinity to human PAK4 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389593Binding affinity to human P38G at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390067Binding affinity to human EPHA1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390000Binding affinity to human ACTR2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390022Binding affinity to human FGFR3 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390041Binding affinity to human TRKB at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390065Binding affinity to human EPHA8 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390013Binding affinity to human YES at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID342142Terminal half life in Lewis rat plasma at 0.5 mg/kg, iv2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID389613Binding affinity to human MST4 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389543Binding affinity to human DMPK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390089Binding affinity to human ADCK4 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389616Binding affinity to human PAK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390035Binding affinity to human ALK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID349065Inhibition of VEGFR22008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
Kinase array design, back to front: biaryl amides.
AID342127Selectivity for human p38alpha over EGFR2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID389580Binding affinity to human DRAK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389599Binding affinity to human SRPK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390073Binding affinity to human LIMK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390042Binding affinity to human TRKC at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389539Binding affinity to human PKACB at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390037Binding affinity to human ROS at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389591Binding affinity to human P38A at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389579Binding affinity to human DRAK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389576Binding affinity to human PLK4 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389611Binding affinity to human MST3 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID342137Inhibition of human recombinant CYP3A4 transfected in Escherichia coli co-expressed with human NADPH reductase2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID389612Binding affinity to human YSK1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389540Binding affinity to human PKG1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389637Binding affinity to human ALK4 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389542Binding affinity to human MRCKA at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390070Binding affinity to human JAK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390084Binding affinity to human CK1gamma1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389577Binding affinity to human DAPK3 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390059Binding affinity to human EPHA6 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID341051Inhibition of HSP27 phosphorylation in IL-1-alpha-stimulated HLF cells2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes.
AID349064Inhibition of SGK12008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
Kinase array design, back to front: biaryl amides.
AID389548Binding affinity to human CAMK1A at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390047Binding affinity to human TYRO3 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389537Binding affinity to human RSK4 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389549Binding affinity to human CAMK1D at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID341194Inhibition of p38beta2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes.
AID389626Binding affinity to human NEK6 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389605Binding affinity to human KHS2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID341054Inhibition of LPS-stimulated TNFalpha release in human PBMC by ELISA2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes.
AID389624Binding affinity to human NEK2 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID349066Inhibition of LPS-stimulated TNFalpha release in human PBMCs2008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
Kinase array design, back to front: biaryl amides.
AID389592Binding affinity to human P38B at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389587Binding affinity to human NLK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389566Binding affinity to human PIM1 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390039Binding affinity to human IGF1R at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID342129Selectivity for human p38alpha over GSK3-beta2008Bioorganic & medicinal chemistry letters, Aug-01, Volume: 18, Issue:15
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
AID389552Binding affinity to human CAMK2D at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390016Binding affinity to human FRK at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389631Binding affinity to human BIKE at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390048Binding affinity to human MET at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID349060Inhibition of ErbB42008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
Kinase array design, back to front: biaryl amides.
AID390060Binding affinity to human EPHA7 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID390051Binding affinity to human EGFR at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389625Binding affinity to human NEK9 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
AID389622Binding affinity to human ULK3 at 10 uM relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.33 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]